Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001955319-24-000001
Filing Date
2024-09-13
Accepted
2024-09-13 16:35:58
Documents
1
Effectiveness Date
2024-09-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7379
  Complete submission text file 0001955319-24-000001.txt   8509
Mailing Address 11757 W. KEN CARYL AVENUE SUITE F, 520 LITTLETON CO 80127-3719
Business Address 11757 W. KEN CARYL AVENUE SUITE F, 520 LITTLETON CO 80127-3719 303-868-6790
Nexo Therapeutics, Inc. (Filer) CIK: 0001955319 (see all company filings)

EIN.: 883136741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-465438 | Film No.: 241298257